Spend more time finding a cure and less time finding and redacting PHI.
In my previous post, the fourth in a series of seven blog posts that discuss some of the misconceptions about lab interfaces and intelligent clinical data extraction software, I addressed the belief that if a hospital has an in-house laboratory, all test results will be integrated with the patient record in the EMR.
In the course of a clinical research project or trial, researchers must gather patient data and records and prepare them for adjudication and analysis. In keeping with the spirit of HIPAA and PHI regulations, the organization conducting this research or trial likely wishes to control access from both within and outside of its firewall to ensure that any potential for breach of this personal information is strictly curtailed.
As I’m standing in line at my favorite coffee shop, I’m thinking about how baristas have perfected workflow; and now have improved perfection by allowing me to eliminate the line entirely by ordering in advance with my smart phone. It always excites me when I see a sequence of steps refined for optimum efficiency. I know it's odd, but I'm really strange like that.
In our next series of blogs, we will discuss the concept of outreach and how programs can use it to improve not only their volumes, but also their outcomes. Outreach can be simplistically defined as the act of reaching out to a group. It may also be defined as a systematic attempt to provide services beyond conventional limits to a particular segment of the community. In this blog, we will concentrate on the former definition, namely, reaching out to different groups to grow our program.
There’s been a lot of news lately about the 2015 NIH budget being flat, worrying researchers that the funding pinch will have a significant impact on current and future projects. Even Nobel prize winning researcher Craig Mello from the University of Massachusetts Medical School recently commented on the impact this could have on his ongoing work, noting that if he couldn’t get a grant he’s applied for he may have to reduce staff.
The role of the cancer registrar is essential in the effort to gather vital information for treatment planning, research studies and in the conduct of clinical trials. Further, as quality of data is more closely looked at in this era of monitoring patient outcomes with a financial eye, already overburdened cancer programs and state registries are doing their best to cope with an ever increasing volume of work. The new CTR standard seeks to ensure the quality of this data collected by cancer registrars is optimized.